Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09037 | Pembrolizumab | 1 / 2 | Terminated | 1 |
| DB17072 | Tabelecleucel | 1 / 2 | Terminated | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09037 | Pembrolizumab | 1 / 2 | Terminated | 1 |
| DB17072 | Tabelecleucel | 1 / 2 | Terminated | 1 |